AMPLIVIR

AmpliVIR™ is a mission-driven, pre-clinical development program exploring the potential of a modern infectious-disease treatment platform- an RNA-based treatment that is replicated by a viral infection, inactivates infectious virus, and offers subviral gene silencing to treat later stages of infection-associated disease. SARS-2 AmpliVIR is proof-of-concept intranasal product of this platform for the treatment of SARS-2 infections... AmpliVIR RNA is an experimental platform for viral suppression and subviral RNAi as a treament for infection-related disease. SARS-2 AmpliVIR is currently being studied in a pre-clinical setting